| KOTAK CONTRA FUND
An open ended equity Scheme following contrarian investment strategy
An open ended equity Scheme following contrarian investment strategy
| KOTAK CONTRA FUND
An open ended equity Scheme following contrarian investment strategy
(as on September 30, 2026)
Source: $ICRA MFI Explorer, ^^Bloomberg
***As per para 7.2 of SEBI Master circular no. HO/24/13/11(1)2026-IMD-POD-1/I/7602/2026 dated March 20, 2026 The first tier benchmark is reflective of the category of the scheme and the second tier benchmark is demonstrative of the investment style / strategy of the Fund Manager within the category.
## Risk rate assumed to be 5.28% (FBIL Overnight MIBOR rate as on 30th September 2026).**The expense ratio disclosed above represents the Base Expense Ratio (BER), including applicable statutory levies on expenses forming part of the BER, but excludes brokerage, transaction costs and related statutory levies. For Total Expense Ratio including brokerage, transaction cost and related statutory levies please refer our website: https://www.kotakmf.com/Information/TER.
* For Fund Manager experience, please refer 'For Regular Plan' & 'For Direct Plan'
For last three IDCW, please refer 'Dividend History'.
For scheme performance, please refer 'For Regular Plan' & 'For Direct Plan'
An open ended equity Scheme following contrarian investment strategy
 |
 |
  
|
|
|
|
Investment Objective
The investment objective of the Scheme is to generate capital appreciation from a diversified portfolio of equity and equity related instruments. The Scheme will invest in stocks of companies, which are fundamentally sound but are undervalued Undervalued stocks are stocks of those companies whose true long term potential is not yet recognised by the market. At times, the broad market takes time to appreciate the long-term potential of some fundamentally sound companies. Stocks of such companies are traded at prices below their intrinsic value and are regarded as undervalued stocks. We believe that, over a period of time, the price of a stock reflects the intrinsic value of the underlying company. Thus, the moving up of the price of the undervalued stock towards its intrinsic value will help us generate capital appreciation for investors. There is no assurance that the investment objective of the Scheme will be achieved.
The investment objective of the Scheme is to generate capital appreciation from a diversified portfolio of equity and equity related instruments. The Scheme will invest in stocks of companies, which are fundamentally sound but are undervalued Undervalued stocks are stocks of those companies whose true long term potential is not yet recognised by the market. At times, the broad market takes time to appreciate the long-term potential of some fundamentally sound companies. Stocks of such companies are traded at prices below their intrinsic value and are regarded as undervalued stocks. We believe that, over a period of time, the price of a stock reflects the intrinsic value of the underlying company. Thus, the moving up of the price of the undervalued stock towards its intrinsic value will help us generate capital appreciation for investors. There is no assurance that the investment objective of the Scheme will be achieved.
| Issuer/Instrument | % to Net Assets |
|
|---|---|---|
| Equity & Equity related | ||
| Banks | 22.26 | |
| ICICI Bank Ltd. | 5.93 | |
| HDFC Bank Ltd. | 5.06 | |
| STATE BANK OF INDIA | 3.24 | |
| INDIAN BANK | 1.63 | |
| JAMMU AND KASHMIR BANK LTD. | 1.50 | |
| Axis Bank Ltd. | 1.48 | |
| IndusInd Bank Ltd. | 1.43 | |
| BANK OF MAHARASHTRA | 1.32 | |
| SOUTH INDIAN BANK LTD. | 0.67 | |
| Finance | 8.20 | |
| SHRIRAM FINANCE LTD. | 2.53 | |
| POONAWALLA FINCORP LTD. | 2.09 | |
| BAJAJ FINANCE LTD. | 1.49 | |
| PIRAMAL FINANCE LTD | 1.44 | |
| L&T FINANCE LTD | 0.65 | |
| IT - Software | 5.93 | |
| Tech Mahindra Ltd. | 2.10 | |
| Mphasis Ltd | 2.00 | |
| Infosys Ltd. | 1.83 | |
| Pharmaceuticals and Biotechnology | 5.47 | |
| Sun Pharmaceuticals Industries Ltd. | 1.70 | |
| Ipca Laboratories Ltd. | 1.68 | |
| Ajanta Pharma Ltd. | 1.19 | |
| VIYASH SCIENTIFIC LTD. | 0.90 | |
| Healthcare Services | 5.42 | |
| Fortis Healthcare India Ltd | 1.98 | |
| PARK MEDI WORLD LIMITED (PARK HOSPITAL) | 1.77 | |
| Metropolis Healthcare Ltd. | 1.10 | |
| Global Health Ltd. | 0.57 | |
| Automobiles | 4.63 | |
| Hero MotoCorp Ltd. | 2.67 | |
| Maruti Suzuki India Limited | 1.96 | |
| Telecom - Services | 4.12 | |
| Bharti Airtel Ltd | 2.42 | |
| Indus Towers Ltd. | 1.70 | |
| Construction | 3.69 | |
| Larsen And Toubro Ltd. | 2.50 | |
| KALPATARU PROJECTS INTERNATIONAL LIMITED | 1.19 | |
| Auto Components | 3.47 | |
| Schaeffler India Ltd | 1.42 | |
| UNO MINDA LIMITED | 1.07 | |
| TENNECO CLEAN AIR INDIA LIMITED | 0.98 | |
| Aerospace and Defense | 3.45 | |
| Bharat Electronics Ltd. | 1.50 | |
| ASTRA MICROWAVE PRODUCTS LTD. | 1.27 | |
| AXISCADES TECHNOLOGIES LTD | 0.68 | |
| Cement and Cement Products | 3.13 | |
| Ultratech Cement Ltd. | 1.85 | |
| Dalmia Bharat Limited | 1.28 | |
| Retailing | 2.92 | |
| SWIGGY LTD | 2.26 | |
| VISHAL MEGA MART LIMITED | 0.66 | |
| Petroleum Products | 2.70 | |
| RELIANCE INDUSTRIES LTD. | 2.70 | |
| Ferrous Metals | 2.48 | |
| Jindal Steel & Power Ltd. | 1.38 | |
| Tata Steel Ltd. | 1.10 | |
| Power | 2.46 | |
| NTPC LTD | 2.46 | |
| Consumer Durables | 2.38 | |
| V-Guard Industries Ltd. | 1.33 | |
| Century Plyboards (India) Ltd. | 1.05 | |
| Industrial Manufacturing | 1.93 | |
| INDO-MIM LTD | 1.93 | |
| Industrial Products | 1.50 | |
| KEI INDUSTRIES LTD. | 1.06 | |
| LUMINO INDUSTRIES LIMITED | 0.44 | |
| Transport Services | 1.32 | |
| Inter Globe Aviation Ltd | 1.32 | |
| Healthcare Equipment and Supplies | 1.31 | |
| MOLBIO DIAGNOSTICS LIMITED | 1.31 | |
| Chemicals and Petrochemicals | 1.30 | |
| SRF Ltd. | 1.30 | |
| Capital Markets | 1.25 | |
| SBI FUNDS MANAGEMENT LIMITED | 0.87 | |
| NATIONAL STOCK EXCHANGE OF INDIA LIMITED (NSE) | 0.38 | |
| Electrical Equipment | 1.18 | |
| GE VERNOVA T&D INDIA LIMITED | 1.18 | |
| Agricultural, Commercial and Construction Vehicles | 1.11 | |
| ASHOK LEYLAND LTD. | 1.11 | |
| Realty | 1.04 | |
| DLF Ltd. | 1.04 | |
| Beverages | 1.02 | |
| RADICO KHAITAN LTD. | 1.02 | |
| Financial Technology (Fintech) | 0.97 | |
| PINE LABS LTD. | 0.97 | |
| Personal Products | 0.95 | |
| Godrej Consumer Products Ltd. | 0.95 | |
| Non - Ferrous Metals | 0.80 | |
| Hindalco Industries Ltd | 0.80 | |
| Diversified FMCG | 0.56 | |
| ITC Ltd. | 0.56 | |
| Equity & Equity related - Total | 98.95 | |
| Triparty Repo | 1.51 | |
| Net Current Assets/(Liabilities) | -0.46 | |
| Grand Total | 100.00 | |
| | ||
| Monthly SIP of (₹) 10000 | Since Inception | 10 years | 7 years | 5 years | 3 years | 1 year |
| Total amount invested (₹) | 25,50,000 | 12,00,000 | 8,40,000 | 6,00,000 | 3,60,000 | 1,20,000 |
| Total Value as on Sep 30, 2026 (₹) | 1,30,55,692 | 25,38,538 | 14,01,059 | 7,82,994 | 3,75,404 | 1,15,645 |
| Scheme Returns (%) | 13.47 | 14.34 | 14.36 | 10.59 | 2.74 | -6.69 |
| Nifty 500 (TRI) Returns (%) | 12.39 | 12.39 | 12.10 | 8.05 | 1.94 | -6.64 |
| Alpha* | 1.08 | 1.95 | 2.26 | 2.54 | 0.80 | -0.05 |
| Nifty 500 (TRI) (₹)# | 1,13,33,409 | 22,87,734 | 12,92,356 | 7,34,944 | 3,70,854 | 1,15,675 |
| Nifty 100 (TRI) Returns (%) | 11.71 | 10.67 | 9.70 | 5.74 | -0.11 | -10.96 |
| Alpha* | 1.77 | 3.67 | 4.67 | 4.85 | 2.86 | 4.27 |
| Nifty 100 (TRI) (₹)# | 1,03,64,807 | 20,87,762 | 11,86,169 | 6,93,649 | 3,59,374 | 1,12,810 |
| Nifty 50 (TRI) (₹)^ | 97,26,237 | 20,37,367 | 11,50,994 | 6,73,946 | 3,52,171 | 1,11,040 |
| Nifty 50 (TRI) Returns (%) | 11.22 | 10.21 | 8.86 | 4.60 | -1.42 | -13.60 |
Scheme Inception : - July 27,2005. The returns are calculated by XIRR approach assuming investment of ₹ ₹ 10,000/- on the 1st working day of every month. Since Inception returns are assumed to be starting from the inception date of the Scheme and
calculated accordingly. XIRR helps in calculating return on investments given an initial and final value and a series of cash inflows and outflows and taking the time of investment into consideration. The SIP performance details provided herein
are of Regular Plan - Growth Option Different plans have different expense structure. # Benchmark; ^ Additional Benchmark. TRI – Total Return Index, In terms of Para no 7.23 of SEBI Master Circular no. HO/24/13/11(1)2026-IMD-POD-
1/I/7602/2026 dated March 20, 2026, the performance of the scheme is benchmarked to the Total Return variant (TRI) of the Benchmark Index instead of Price Return Variant (PRI). Alpha is difference of scheme return with benchmark return. *All payouts during the
period have been reinvested in the units of the scheme at the then prevailing NAV. Source: ICRA MFI Explorer.
Net Asset Value (NAV)
| Regular | Direct | |
| Growth | Rs145.9560 | Rs174.7540 |
| IDCW | Rs50.3100 | Rs62.1860 |
Available Plans/Options
A) Regular Plan B) Direct Plan
Options: Payout of IDCW, Reinvestment of
IDCW & Growth (applicable for all plans)
| Fund Manager* | Ms. Shibani Sircar Kurian |
| Benchmark*** | Nifty 500 TRI (Tier 1), Nifty 100 TRI (Tier 2) |
| Allotment date | July 27, 2005 |
| AAUM | Rs5,361.82 crs |
| AUM | Rs5,196.35 crs |
| Folio count | 1,50,180 |
IDCW Frequency
Trustee's Discretion
Ratios
| Portfolio Turnover | 38.73% |
| $Beta | 1.00 |
| $Sharpe ## | 0.48 |
| $Standard Deviation | 16.12% |
| ^^(P/E) | 23.05 |
| ^^P/BV | 2.79 |
Market Capitalisation*
| Large Cap | 51.23% |
| Mid Cap | 28.81% |
| Small Cap | 18.91% |
| Debt & Money Market | 1.05% |
*% of Net Asset
Minimum Investment Amount
Initial & Additional Investment
• Rs100 and any amount thereafter
Systematic Investment Plan (SIP)
• Rs 100 and any amount thereafter
Ideal Investments Horizon
• 5 years & above
Load Structure
Entry Load:
Nil. (applicable for all plans)
Exit Load:
• For redemption / switch out within 90
days from the date of allotment: 1%
• If units are redeemed or switched out on
or after 90 days from the date of allotment -
Nil.
Expense Ratio**
| Regular Plan: | 1.88% |
| Direct Plan: | 0.65% |
Data as on 30th September, 2026 unless
otherwise specified.
Folio Count data as on 31st August 2026.
Folio Count data as on 31st August 2026.
Fund
Benchmark - Tier 1 : Nifty 500 TRI
Benchmark - Tier 2 : Nifty 100 TRI
This product is suitable for investors who are seeking*:
Benchmark - Tier 1 : Nifty 500 TRI
Benchmark - Tier 2 : Nifty 100 TRI
This product is suitable for investors who are seeking*:
- Long term capital growth
- Investment in portfolio of predominantly equity & equity related securities.
* Investors should consult their financial advisors if in doubt about whether the product is suitable for them.
For latest Riskometer, investors may refer to an addendum issued or updated on website at www.kotakmf.com
***As per para 7.2 of SEBI Master circular no. HO/24/13/11(1)2026-IMD-POD-1/I/7602/2026 dated March 20, 2026 The first tier benchmark is reflective of the category of the scheme and the second tier benchmark is demonstrative of the investment style / strategy of the Fund Manager within the category.
## Risk rate assumed to be 5.28% (FBIL Overnight MIBOR rate as on 30th September 2026).**The expense ratio disclosed above represents the Base Expense Ratio (BER), including applicable statutory levies on expenses forming part of the BER, but excludes brokerage, transaction costs and related statutory levies. For Total Expense Ratio including brokerage, transaction cost and related statutory levies please refer our website: https://www.kotakmf.com/Information/TER.
* For Fund Manager experience, please refer 'For Regular Plan' & 'For Direct Plan'
For last three IDCW, please refer 'Dividend History'.
For scheme performance, please refer 'For Regular Plan' & 'For Direct Plan'